<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>mirtazapine &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/mirtazapine/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 04 Nov 2025 21:44:05 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>mirtazapine &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Evaluating Costs of Repurposing Mirtazapine for Breathlessness</title>
		<link>https://bioengineer.org/evaluating-costs-of-repurposing-mirtazapine-for-breathlessness/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 04 Nov 2025 21:43:49 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[BETTER-B trial]]></category>
		<category><![CDATA[Drug repurposing]]></category>
		<category><![CDATA[economic evaluation]]></category>
		<category><![CDATA[mirtazapine]]></category>
		<category><![CDATA[severe breathlessness]]></category>
		<guid isPermaLink="false">https://bioengineer.org/evaluating-costs-of-repurposing-mirtazapine-for-breathlessness/</guid>

					<description><![CDATA[In a groundbreaking study published in BMC Health Services Research, the focus is on drug repurposing, particularly examining the economic implications of utilizing mirtazapine for severe breathlessness. The research, which forms part of the multinational BETTER-B trial, aims to address a significant gap in our understanding of how existing medications can be adapted for new [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">291518</post-id>	</item>
	</channel>
</rss>
